VKTX
Viking Therapeutics IncPer-minute rate limit hit. Wait a moment and refresh.
As of 1d ago
0–100 scale across 90-day window
VKTX isn't in the top 300 most-mentioned tickers on Reddit right now.
$BMEA because all current glp-1s got 6.8% placebo adjust reduction weight loss well $VKTX did in humans in 28 days. All current glp-1s have heavy side effects. All current glp-1s have to titrate to 4 to 8 steps. Biomeas glp-1 is looking to improve all 3 1.) better weight loss as In monkeys in 28 days it got 15.2% weight loss hopefully in humans also 2.) it’s built to have better pk binding to avoid nausea, vomiting, and all heavy side effects that plague wegovy pill and foundayo 3.) it’s pk profile might allow 2 step titration better than all glp1 drugs that now require 4 to 8 steps titration BMF-650 is not being developed as a me too. They might solve all 3 problems. Like someone said if data is homerun this definitely restates even if only phase 1 They added a 2 step titration phase 1 to see if possible. 200 mg for one week then jump straight to 400 mg for next 3 weeks. If low dropouts and good weight loss this booms into the stratosphere
$AXSM Perfect example of what a fkbrain this troll is ! $VKTX Lmao!
@ReneDif Alt has class leading data. Mgmt is yet to be proven. There is no point arguing. We agree on structure, disagree on $VKTX All the best